Editorial Board Member - JMBS
Esam Z. Dajani
Adjunct Professor of MedicineLoyola University
USA
BIOGRAPHY:
Professor Esam Z. Dajani, Ph.D., FACG is the founder and president of International Drug Development Consultants (IDDC) Corporation, a Contract Research Organization (CRO) which provides scientific consulting services to pharmaceutical companies, law firms, and governmental agencies. The scope of the consulting service includes clinical pharmacology, toxicology, drug development and regulatory affairs. He has directed worldwide clinical research and development at major pharmaceutical companies. He led the research teams that discovered and developed misoprostol (Cytotec), an anti-ulcer drug. Since 1980, he held continuous academic appointments in pharmacology and in medicine. He is currently serving as Adjunct Professor of Medicine at Loyola University-Chicago. He taught pharmacology and toxicology to medical, dental and pharmacy students. He has research interests in clinical pharmacology, gastrointestinal pharmacology, central nervous system pharmacology, prostaglandins, non-steroidal anti-inflammatory drugs (NSAIDs), growth hormones (e.g., epidermal growth factor), cannabinoids and narcotic analgesics.
Other Editorial Board Members - JMBS
Muhammad Akram
Government College University Faisalabad
Pakistan
Change Tan
University of Missouri
USA
Viroj Wiwanitkit
Hainan Medical University
China
Ahmed Ragab Gaber Ahmed
Beni-Suef University
Egypt
Anuradha Ratna
University of Massachusetts Medical School
USA
Mohammad Waheed El-Anwar
Department of otorhinolaryngology
Zagazig University
Egypt
Ramesh C. Gupta
Nagaland University
India
Giuseppe Lanza
University of Catania
Italy
Raffaele Pezzani
University of Padova
Italy
Mohamed Abdo Rizk
Department of Internal Medicine and Infectious Diseases
Mansoura University
Egypt